The Arthritis Society, Canada Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02936180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

The Arthritis Society, Canada

Active Ingredients

Drugs in Phase 4 Trials (2)

inactivated influenza vaccine (1 trial)

tivantinib (1 trial)

Drugs in Phase 2 Trials (1)

vitamin c (1 trial)

Drugs in Other Trials (2)

methotrexate (1 trial)

ondansetron (zofran) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Influenza, Human (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5